Leishmaniasis: drugs in the clinic, resistance and new developments
- PMID: 15533763
- DOI: 10.1016/j.drup.2004.07.002
Leishmaniasis: drugs in the clinic, resistance and new developments
Abstract
The control of Leishmania infections relies primarily on chemotherapy. The arsenal of drugs available for treating Leishmania infections is limited and includes pentavalent antimonials, pentamidine, amphotericin B, miltefosine, fluconazole and few other drugs at various stages of their development process. In this review, we will discuss the latest results regarding resistance mechanisms to drugs used in the clinic against Leishmania infections.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
